Compound Contains Two Or More C(=o)o Groups Patents (Class 514/547)
-
Publication number: 20100331345Abstract: The present invention relates to compounds represented by formula (I), or isomers, prodrugs, pharmaceutically acceptable salts, solvates or hydrates thereof: in which each substituent of formula (I) is as defined in the specification. The present invention also relates to preparation methods of compounds represented by formula (I), a pharmaceutical composition comprising compounds represented by formula (I) and usage of compounds represented by formula (I) for treating chronic neurodegenerative diseases such as Alzheimer's disease and other diseases induced by aggregation or deposition of ?-amyloid peptide.Type: ApplicationFiled: February 5, 2007Publication date: December 30, 2010Inventors: Song Li, Guochao Liao, Junhai Xiao, Aihua Nie, Lili Wang, Wu Zhong, Zhibing Zheng
-
Publication number: 20100324136Abstract: The present invention provides an oily base for a cosmetic comprising an ester compound made from a multivalent alcohol and a fatty acid, characterized in that the ester compound is made from pentaerythritol and isononanoic acid and a molar ratio of a pentaerythritol residue and an isononanoic acid residue in the ester compound is 1.0:2.3 to 1.0:4.0. The oily base for a cosmetic of the present invention has proper oily feeling with moistness, no sticky feeling, excellent adhesion to the skin and safety to the skin, and excellent compatibility with oil agents, among others, silicone oil. Furthermore, upon blending the present oily base in a cosmetic, besides having proper emollient property and moisturizing property, the cosmetic exhibits smooth feeling on use, excellent adhesion to the skin and safety to the skin, excellent cosmetic effect-holding ability, and storage stability.Type: ApplicationFiled: June 17, 2010Publication date: December 23, 2010Applicant: Kokyu Alcohol Kogyo Co., Ltd.Inventors: Nana Arahira, Yuki Kokeguchi, Kiyotaka Kawai
-
Patent number: 7854939Abstract: A gel, for cosmetic use, composed of a mixture of a polymer which forms a gel, a surfactant, and propionyl L-carnitine glycinate hydrochloride, useful for treating disturbances of the skin such as cellulite and wrinkles is described.Type: GrantFiled: November 9, 2007Date of Patent: December 21, 2010Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.Inventors: Antonio Longo, Mose Santaniello, Paola Risi
-
Patent number: 7851505Abstract: The current invention provides novel thiotungstate derivatives, methods of making novel thiotungstate derivatives, pharmaceutical compositions of novel thiotungstate derivatives, methods of using novel thiotungstate derivatives to treat diseases associated with aberrant vascularization, copper metabolism disorders and obesity and methods of using pharmaceutical compositions of thiotungstate derivatives to treat diseases associated with aberrant vascularization, copper metabolism disorders, neurodegenerative disorders, obesity or NF-?B dysregulation.Type: GrantFiled: May 27, 2004Date of Patent: December 14, 2010Assignee: Attenuon, LLCInventors: Robert J. Ternansky, Patricia L. Gladstone, Amy L. Allan, Melissa L. P. Price, Andrew Mazar
-
Publication number: 20100311832Abstract: The present invention pertains to the use for preventing or treating intestinal infections caused by gram-positive bacteria in animals of an antibacterial compound selected from lactylate in accordance with formula 1, Formula 1 R2 -COO—[—CH(CH3)—COO]n—R1 or a Na, K, Ca, Mg, Fe(II), Zn, NH4, or Cu(II) salt thereof, a glycolylate of formula 2, Formula 2: R2-COO—[—CH2-COO]n—R1 or a Na, K, Ca, Mg, Fe(II), Zn, NH4, or Cu(II) salt thereof, a lactate ester of formula 3, Formula 3: HO—CH(CH3)—COO—R2 and/or a glycolic acid ester of formula 4, Formula 4: HO—CH2-COO—R2 wherein R1 is selected from H, n stands for an integer with a value of 1-10, and R2 stands for a C1-C35 alkyl or alkenyl chain which may be branched or unbranched. The compound, which preferably is a lactylate or a Na, K, Ca, Mg, Fe(II), Zn, NH4, or Cu(II) salt thereof, is particularly useful in the treatment or prevention of Clostridia. An animal nutrition composition and a method for preventing or treating infections are also claimed.Type: ApplicationFiled: January 23, 2009Publication date: December 9, 2010Applicant: Purac Blochem BVInventor: Anne Cazemier
-
Publication number: 20100311831Abstract: A process for the removal of sterols, specifically cholesterol, from a triglyceride oil, preferably a marine triglyceride oil, said process comprising contacting an oil with an absorbent, specifically TRIS YL™, clay or a mixture thereof, heating the mixture to 100° C. to 210° C., preferably 150° C. to 170° C., preferably for a time period of greater than one minute and optionally at a pressure less than 1.33 Pa, preferably less than 1.33 Pa.Type: ApplicationFiled: July 30, 2010Publication date: December 9, 2010Applicant: OCEAN NUTRITION CANADA LIMITEDInventor: Weijie WANG
-
Patent number: 7846969Abstract: A process for the production of a stabilized ceramide emulsion by adding one or more ceramides of Formula (2) to one or more sphingosines of Formula (1), and then adding an acidic compound and water to form one or more sphingosine salts, wherein the sphingosine salts emulsify the ceramides to form the emulsion.Type: GrantFiled: December 10, 2002Date of Patent: December 7, 2010Assignee: Kao CorporationInventors: Yumiko Yamamoto, Masanori Tanahashi
-
Publication number: 20100303913Abstract: Methods of nanoencapsulation are described herein. Embodiments of the method utilize the coacervation of a cationic polyelectrolyte with an anionic polyelectrolyte to form a novel capsular matrix. In particular, the novel methods may be used to encapsulate a suspension of a hydrophobic material such as a carotenoid. The disclosed methods do not require lengthy pH adjustments nor do they require the use of any toxic crosslinking agents. In one embodiment, a method of encapsulation comprises dispersing a hydrophobic compound in an organic solvent to form a solution. The method also comprises admixing an anionic polyelectrolyte and a cationic polyelectrolyte with the suspension to form a mixture. In addition, the method comprises quiescently cooling the mixture so as to cause self-crosslinking of a capsular matrix encapsulating the hydrophobic particles.Type: ApplicationFiled: October 31, 2006Publication date: December 2, 2010Applicant: WILLIAM MARSH RICE UNIVERSITYInventors: Muhammed K. Gheith, Yu-Lun Fang, Michael S. Wong
-
Publication number: 20100305204Abstract: The present invention relates to the use of acetyl L-carnitine, or a pharmaceutically acceptable salt thereof, for the prevention of the adverse effects, such as osteoporosis, weight gain and edema, due to the use of PPAR-gamma agonists selected from the group consisting of spirolaxine or a glitazonederivative selected from the group consisting of roglitazone, pioglitazone androsiglitazone.Type: ApplicationFiled: April 28, 2008Publication date: December 2, 2010Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.Inventors: Menotti Calvani, Stefania D'Iddio, Paola Benatti
-
Publication number: 20100300044Abstract: The present invention is directed to wetting agent compositions and methods for making and using the wetting agent compositions. The compositions of the invention include a sheeting agent, a defoaming agent, and an association disruption agent. The wetting agent compositions of the present invention result in a faster draining/drying time on most substrates compared to conventional wetting agents. The wetting agent compositions of the present invention are especially suitable for use on plastic substrates.Type: ApplicationFiled: May 12, 2010Publication date: December 2, 2010Applicant: ECOLAB USA INC.Inventors: Victor F. Man, Janel M. Kieffer, Michael C. Denoma, Yvonne M. Killeen, Joshua P. Magnuson
-
Patent number: 7842726Abstract: To provide novel carnitine derivatives and salts thereof that are resistant to hydrolysis in the presence of aqueous media, and also provide external skin preparations and cosmetics that are excellent in storage stability, product life, skin affinity and percutaneous absorption properties. In particular, to provide novel ?-branched acyl carnitine derivatives and salts thereof, external skin preparations and cosmetics comprising specific ?-branched acyl carnitine derivatives and/or salts thereof.Type: GrantFiled: September 21, 2006Date of Patent: November 30, 2010Assignee: Showa Denko K.K.Inventors: Hirobumi Aoki, Harumi Kamachi, Yohei Kurata
-
Publication number: 20100297460Abstract: According to the invention, wood material is treated with a composition comprising at least one C1-C7 monocarboxylic acid or a salt, or mixtures thereof, and at least one chelating agent. These compounds are dissolved in a liquid aqueous vehicle. In this manner, the treated wood is endowed with excellent resistance against detrimental environmental effects.Type: ApplicationFiled: December 3, 2008Publication date: November 25, 2010Applicant: KEMIRA OYJInventors: Jari-Jukka Kukkonen, Timo Nissinen, Reijo Aksela
-
Publication number: 20100292326Abstract: The invention relates to pharmaceutical compositions comprising S-nitrosoglutathione and one or more polysaccharide-type polimer(s) together with one or more pharmaceutically accepted polymer(s) and additive(s). The invention is based on the discovery that polysaccharide-type polymers (such as chitosan) are capable of stabilizing the otherwise highly labile GSNO.Type: ApplicationFiled: October 16, 2008Publication date: November 18, 2010Inventors: Zsombor Lacza, István Hornyák
-
Publication number: 20100286269Abstract: Use of medium-chain length fatty acids such as capric acid, caprylic acid or lauric acid and their salts or mono- or di- or triglycerides as nephroprotection agents to protect against renal failure progression in chronic kidney diseases This includes the treatment of kidney diseases associated with nephrectomy, renal fibrosis, glomerular scelrosis and end-stage renal disease Also includes the protection of the kidney against cytotoxic agent used in chemotherapy or autoimmune diseases or transplantation Further includes the treatment of renal failure progression associated with hypertension, infarct, tumour, diabetes mellitus, autoimmunity or inflammation.Type: ApplicationFiled: November 3, 2008Publication date: November 11, 2010Applicant: Prometic Biosciences Inc.Inventors: Vincent Pichette, Francois Leblond, Mouna Lagraoui, Lyne Gagnon
-
Publication number: 20100280113Abstract: The invention is directed to novel pharmaceutical compositions comprising chemicals agents that are useful in the treatment and prevention of cystic fibrosis and the prevention of signs and symptoms of this disease. These pharmaceutical compositions are surprisingly successful in the treatment disorders related to cystic fibrosis including disorders of blood production. Many of these compositions of the invention are even more effective when administered to a patient in pulses. Pulse therapy is not a form of discontinuous administration of the same amount of a composition over time, but comprises administration of the same dose of the composition at a reduced frequency or administration of reduced doses.Type: ApplicationFiled: July 14, 2010Publication date: November 4, 2010Applicant: TRUSTEES OF BOSTON UNIVERSITYInventors: Douglas V. Faller, Susan P. Perrine, George Stamatoyannopoulos
-
Publication number: 20100279959Abstract: A composition and method for promoting neutrophil survival and activation such as the treatment of neutropenia arising as an undesirable side effect of chemotherapy and radiation therapy. A composition containing medium-chain fatty acids, such as Capri acid or caprylic acid, or salts or triglycerides thereof, or mono- or diglycerides or other analogues thereof or medium-chain triglycerides (MCT) is administered to a human or animal needing treatment in an amount sufficient to reduce or eliminate neutropenia. The composition is administered in an amount effective to treat the disorder. The methods are also useful in the management of bone narrow transplantation and in the treatment of various neutropenic diseases.Type: ApplicationFiled: June 11, 2010Publication date: November 4, 2010Inventors: Lyne Gagnon, Jean Barabe, Pierre Laurin, Christopher Penney, Boulos Zacharie
-
Publication number: 20100280111Abstract: An object of the present invention is to provide skin external preparations and cosmetics which contain a branched acyl carnitine and have excellent formulation stability. A skin external preparation of the present invention includes a carnitine derivative represented by the following Formula (1) and/or a carnitine derivative salt represented by the following Formula (2), and an amphoteric surfactant. In Formula (1), R1 and R2 are each independently a C1-18 optionally branched, saturated or unsaturated aliphatic hydrocarbon group. In Formula (2), R1 and R2 are the same as in Formula (1), X? is a specific anion and Y+ is a specific cation.Type: ApplicationFiled: December 19, 2008Publication date: November 4, 2010Applicant: SHOWA DENKO K.K.Inventors: Hirobumi Aoki, Harumi Kamachi
-
Publication number: 20100280112Abstract: The present invention relates to an oil composition containing a large amount of a. diglyceride of conjugated linoleic acid (CLA), and more particularly to an oil composition with body weight control, anticancer, antioxidation and immune enhancement functions, which is based on a diglyceride of conjugated linoleic acid resulted from an enzymatic reaction between conjugated linoleic acid obtained from edible oil and glycerol. The inventive oil composition comprises 40-95% by weight of diglycerides, 5-60% by weight of triglycerides, 0.110% by weight of monoglycerides, and 0.02-10% by weight of residues, in which the ratio of conjugated linoleic acid (CLA) to fatty acids contained in the total glycerides is 5-98%. The use of the oil composition provides high-added-value foods, pharmaceutical compositions and foodstuff additives with effects of anticancer, immune enhancement, antioxidation, antichlorestol, growth promotion and the like.Type: ApplicationFiled: July 14, 2010Publication date: November 4, 2010Applicant: KIP BIOTECH LLCInventors: Untaek Lee, Jeeyoung Kim, Moonwon Lee, Sunyoung Choi
-
Publication number: 20100272655Abstract: Described is a new cooling agent represented by Structure I and compositions with known coolers having cooling properties and the application of Structure I in foodstuffs and chewing gum:Type: ApplicationFiled: April 27, 2009Publication date: October 28, 2010Inventors: Kathryn Anne Bardsley, Mark L. Dewis, Brian Trevor Grainger, Adam Jan Janczuk, Arkadiusz Kazimierski, Kenneth J. Kraut, John L. Sondrup, Ying Yang
-
Publication number: 20100272726Abstract: A novel class of hydroxylases is described having the amino acid sequence of SEQ ID NO: 2, 4, 6 and 8, and variants and fragments thereof having HIF hydroxylation activity. The polypeptides of the invention have in particular prolyl hydroxylase activity. An assay method monitors the interaction of the HIF hydroxylase with a substrate. Modulators of HIF hydroxylase are provided for use in the treatment of a condition associated with increased or decreased HIF levels or activity or for the treatment of a condition where it is desirable to modulate HIF levels or activity.Type: ApplicationFiled: January 12, 2010Publication date: October 28, 2010Inventors: Patrick Henry Maxwell, Christopher William Pugh, Peter John Ratcliffe, Christopher Joseph Schofield
-
Publication number: 20100273749Abstract: The subject application provides an aqueous composition suitable for use as an artificial tear solution comprising one or more lipids produced by an enzyme of the diacylglycerol acyltransferase 2 (DGAT2) family and/or the acyl-CoA cholesterol acytransferase (ACAT) family. This invention also provides related methods.Type: ApplicationFiled: December 28, 2006Publication date: October 28, 2010Inventors: Stephen L. Sturley, Aaron Turkish, Stephen Trokel
-
ANTIBACTERIAL FORMULATION COMPRISING A DIALKYL SULPHOSUCCINATE AND A CARBANILIDE ANTIBACTERIAL AGENT
Publication number: 20100273876Abstract: Antibacterial formulation containing (a) a dialkyl sulphosuccinate (DAS) or derivative thereof and (b) a carbanilide antibacterial agent such as triclocarban (TCC). The formulation may be for use in the treatment of a bacterial condition, in particular acne, body odour or a condition affecting the oral cavity. It may contain, in addition to the DAS and the carbanilide, (i) a poly-oxyalkylene-based solubilising agent; (ii) an organic solvent; (iii) a thickening agent; and (iv) water.Type: ApplicationFiled: June 2, 2008Publication date: October 28, 2010Inventors: Scott Seville, Stephen Philip Jones, Daniel James Fitzgerald, Nayan N. Desai, Refika I. Pakunlu -
Publication number: 20100273877Abstract: An emulsified skin external preparation including 0.01 to 10% by mass of a branched acyl carnitine derivative represented by the following Formula (1) and/or a carnitine derivative salt represented by the following Formula (2), and 0.01 to 20% by mass of a nonionic surfactant: where R1 and R2 are each independently a C1-18 optionally branched, saturated or unsaturated aliphatic hydrocarbon group. In Formula (2), R1 and R2 are the same as in Formula (1), X? is a specific anion and Y+ is a specific cation.Type: ApplicationFiled: December 19, 2008Publication date: October 28, 2010Applicant: SHOWA DENKO K.K.Inventors: Hirobumi Aoki, Harumi Kamachi
-
Publication number: 20100266681Abstract: The present invention relates to a lipid composition comprising at least omega-3 polyunsaturated alcohols, or pro-drugs thereof, which omega-3 polyunsaturated alcohols, or pro-drugs thereof, comprising at least (all-Z)-5,8,11,14,17-eicosapentaen-1-ol, or pro-drug thereof, and (all-Z)-4,7,10,13,16,19-docosahexaen-1-ol, or pro-drug thereof, and their use as a pharmaceutical, in particular for the treatment of elevated triglyceride levels. The invention also relates to methods for the preparation of these pro-drugs from marine oils.Type: ApplicationFiled: November 2, 2007Publication date: October 21, 2010Inventor: Anne Kristin Holmeide
-
Publication number: 20100260735Abstract: A method for promoting the health of a plant comprises administering malic acid to the plant or the soil in an amount effective to recruit plant growth promoting rhizobacteria (PGPR) to the plant. Administration of malic acid promotes biofilm formation of PGPR on the plant's roots, thereby restricting entry of a foliar pathogen through stomatal pores present in the leaves. Another method for promoting the health of a plant comprises administering acetoin to the plant or the soil in an amount effective to increase pathogen resistance in aerial parts of the plant.Type: ApplicationFiled: April 12, 2010Publication date: October 14, 2010Applicant: University of DelawreInventors: Harsh Bais, Amutha Sampath Kumar, Venkatachalam Lakshmannan, Thimmaraju Rudrappa
-
Publication number: 20100261791Abstract: The present invention is related to mammalian nutrition and effects thereof in individuals with age associated cognitive decline such as Age Associated Memory Impairment (AAMI) or a dementing illness such as Alzheimer's disease or related dementia, or Mild Cognitive Impairment, such as improving performance in, or reversal, prevention, reducing and delaying decline in, one or more of cognitive function, memory, behavior, cerebrovascular function, motor function, and/or brain physiology are seen. In particular, the present invention utilizes medium chain triglycerides, in one embodiment, administered as part of a long-term treatment regimen, to preserve or improve learning, attention, motor performance, cerebrovascular function, social behavior, and to increase activity levels, particularly in aging mammals.Type: ApplicationFiled: June 23, 2010Publication date: October 14, 2010Applicant: ACCERA, INC.Inventor: Samuel T. Henderson
-
Publication number: 20100261790Abstract: Use of a mixture comprising a triglyceride oil having a solid fat content at ambient to body temperature and an emulsifier for the preparation of a pharmacologically active composition for increasing body fat mass loss or maintaining blood pressure in an individual. Such use may be carried out subsequent to a period of weight loss. Preferably, the triglyceride oil is fractiorated oil and the emulsifier is galactolipid.Type: ApplicationFiled: May 8, 2008Publication date: October 14, 2010Inventors: Bengt Herslöf, Annika Viberg
-
Publication number: 20100260755Abstract: The invention contemplates methods and compositions for treating multiple sclerosis including the administration of a PDE inhibitor and at least one immunomodulator comprising mitoxantrone, natalizumab, fingolimod, laquinimod, cladribine, dimethylfumarate or a mixture comprising synthetic polypeptide analogs of myelin basic protein, including alanine, glutamic acid, lysine, and tyrosine amino acid residues, in a therapeutically effective amount. A preferred PDE inhibitor includes ibudilast.Type: ApplicationFiled: April 7, 2010Publication date: October 14, 2010Inventors: Richard E. GAMMANS, Kenneth W. Locke, Michael E. Kalafer
-
Publication number: 20100251397Abstract: A polyploid castor plant being at least as fertile as a diploid castor plant isogenic to the polyploid castor plant when grown under similar conditions.Type: ApplicationFiled: November 6, 2008Publication date: September 30, 2010Applicant: Kalima Bio Agritech Ltd.Inventors: Amit Avidov, Alon Lerner
-
Patent number: 7803840Abstract: The present invention relates to the use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets. For this purpose, the dialkyl fumarates may also be used in combination with conventional preparations used in transplantation medicine and immunosuppressive agents, especially cyclosporines.Type: GrantFiled: March 17, 2009Date of Patent: September 28, 2010Assignee: Biogen Idec International GmbHInventors: Rajendra Kumar Joshi, Hans-Peter Strebel
-
Publication number: 20100240616Abstract: Omega-3 lipid compounds of the general formula (I): wherein R1 and R2 are the same or different and are chosen from a hydrogen atom, a hydroxy group, an alkyl group, a halogen atom, an alkoxy group, an acyloxy group, an acyl group, an alkenyl group, an alkynyl group, an aryl group, an alkylthio group, an alkoxycarbonyl group, a carboxy group, an alkylsulfinyl group, an alkylsulfonyl group, an amino group, and an alkylamino group; P represents a hydrogen atom, (Formula II) wherein P2, P3, and P4 are chosen from a hydrogen atom, an alkyl group, and a C14-C22 alkenyl group, wherein the alkyl and alkenyl groups are optionally substituted with a hydroxy group, (Formula III), (Formula IV), or (Formula V); and Y is a C14-C22 alkenyl group with at least one double bond, having E and/or Z configuration; or any pharmaceutically acceptable complex, solvate, salt or pro-drug thereof, with the proviso that R1 and R2 are not simultaneously a hydrogen atom.Type: ApplicationFiled: November 1, 2007Publication date: September 23, 2010Inventors: Anne Kristin Holmeide, Jenny Rosman
-
Publication number: 20100233244Abstract: The present invention relates to a quickly decomposing oral drug preparation, for the application of active ingredient combinations for smoking withdrawal, which contains nicotine, a nicotine salt, a nicotine derivative, or a substance that reacts to nicotine, in combination with another active ingredient, and the use of such a drug preparation for the treatment of smoking withdrawal, and the use of nicotine, and/or nicotine salts or derivatives, for the production of medications for the treatment of smoking withdrawal. The active ingredient that is to be administered, in combination, for this purpose is a centrally active ingredient, preferably an antidepressant for the fighting of psychic dependency in terms of a smoking withdrawal therapy. The administration of the active ingredient combination to the patient should be handled in a simple and reliable way and should exclude side effects to a large extent.Type: ApplicationFiled: June 4, 2007Publication date: September 16, 2010Applicant: LTS Lohmann Therapie-Systeme AGInventors: Hans-Rainer Hoffmann, Reto Brändli, Frank Theobald
-
Publication number: 20100222428Abstract: A seven-carbon fatty acid or derivative thereof has been identified as an excellent energy source for humans or human infants. A nutritional supplement suitable for humans or human infants comprising a seven carbon fatty acid chain compound or derivative thereof can be used to increase energy production derived from fatty acid metabolism. For example, administering a seven carbon fatty acid chain compound or derivative thereof can be used to accelerate the growth rate of a prematurely born human infant.Type: ApplicationFiled: March 8, 2010Publication date: September 2, 2010Applicant: BAYLOR RESEARCH INSTITUTEInventor: Charles R. Roe
-
Publication number: 20100215728Abstract: Disclosed are compositions and methods for skincare, e.g., reducing skin wrinkles and for treating skin disorders.Type: ApplicationFiled: February 5, 2010Publication date: August 26, 2010Applicant: Asan Laboratories Company (Cayman), LimitedInventors: Yih-Lin Chung, Nam-Mew Pui, Wei-Wei Chang
-
Publication number: 20100210695Abstract: The present invention is directed to pharmaceutical compositions formulated for topical administration comprising an inhibitor of carnitine palmitoyl transferase (CPT1) and methods for treating skin disorders, such as psoriasis, by administration of a CPT1 inhibitor. In particular embodiments, the invention provides a pharmaceutical composition formulated for topical administration comprising the CPT1 inhibitor ST1326. In other embodiments, the invention provides a method of treating a skin disorder, such as psoriasis by administration of the CPT1 inhibitor ST1326.Type: ApplicationFiled: June 19, 2008Publication date: August 19, 2010Applicant: DARA BIOSCIENCES, INC.Inventor: John R. Didsbury
-
Publication number: 20100209358Abstract: The invention relates to a method for making composite active particles for use in a pharmaceutical composition for pulmonary administration, the method comprising a milling step in which particles of active material are milled in the presence of particles of an additive material which is suitable for the promotion of the dispersal of the composite active particles upon actuation of an inhaler. The invention also relates to compositions for inhalation prepared by the method.Type: ApplicationFiled: April 26, 2010Publication date: August 19, 2010Applicant: Vectura LimitedInventors: John Nicholas STANIFORTH, Matthew Michael James GREEN, David Alexander Vodden MORTON
-
Publication number: 20100210723Abstract: An object of the present invention is to provide a fat-soluble lipase inhibitor which can contribute to prevention or treatment of obesity due to excessive fat intake or diseases caused by obesity, can be added to fats and oils of all types, and can mildly inhibit hydrolysis by lipase. The present invention is a lipase inhibitor containing, as the active ingredient, at least one substance which is a fat-soluble substance selected from among SLS type triacylglycerols (i.e., symmetric triacylglycerols composed of S which represents a short-chain fatty acid having from 2 to 6 carbon atoms and L which represents a long-chain fatty acid having from 16 to 22 carbon atoms), LUU type and UUL type triacylglycerols (i.e.Type: ApplicationFiled: April 15, 2010Publication date: August 19, 2010Inventors: Toshiharu Arishima, Nobuhiko Tachibana
-
Patent number: 7776914Abstract: The invention is directed to compositions comprising lecithin, olive oil, esterified fatty acids and mixed tocophenols for use in the treatment and prevention of various types of arthritis and other inflammatory joint conditions, periodontal diseases and psoriasis, which avoid many of the side effects associated with known treatments. The compositions of the present invention have the advantage of increased stability, a reduction of arachidonic acid in cells, a reduction in eicosanoid production and enhanced cell regulation and communication. Also disclosed are methods for using the compositions for treatment and prevention.Type: GrantFiled: June 16, 2009Date of Patent: August 17, 2010Assignee: Imagenetix, Inc.Inventors: William P. Spencer, Patrick S. Millsap
-
Patent number: 7777071Abstract: The present invention discloses novel dual prodrug compounds of formula (1), methods for their preparation and intermediates in their syntheses, formula (1): wherein A is a single bond, —O—, or —CH2—; m and n vary independently and are an integer from 1 to 15; p and q vary from 0 to an integer from 1 to 4; B is a single bond or —CR3R4; D is formula (2): or formula (3): and X is halogen; R1 to R4 are various substituents selected to optimize the physiochemical and biological properties such as, lipophilicity, bioavailability, and pharmacokinetics of compounds of Formula 1; and R1 and R2 or R3 and R4 may optionally be tethered together to form a 3- to 7-membered alicyclic ring. These compounds are useful for the treatment of various infections, metabolic, cardiovascular and neurological disorders.Type: GrantFiled: August 11, 2006Date of Patent: August 17, 2010Assignee: SSV Therapeutics, Inc.Inventor: Om P Goel
-
Publication number: 20100204323Abstract: Antimicrobial compositions comprising organic acid esters and methods for reducing virus and/or bacteria populations using such compositions are provided. In one embodiment, an antimicrobial composition comprises a virucidally effective amount of an organic acid ester, the organic acid ester having a pKa1 value in the range of from about 3 to about 4.5. The composition further comprises a disinfecting alcohol present in an amount of 0 wt. % to about 75 wt. % and a carrier. The antimicrobial composition has a pH of no greater than about 5 at 25° C.Type: ApplicationFiled: April 21, 2010Publication date: August 12, 2010Applicant: The Dial CorporationInventors: Richard F. Theiler, Earl P. Seitz, JR., Janice L. Fuls
-
Publication number: 20100204162Abstract: The present invention provides a compound which is an inhibitor of sphingolipid biosynthesis for use in the treatment of a disease which has a secondary Niemann-Pick type C disease like cellular phenotype.Type: ApplicationFiled: June 26, 2008Publication date: August 12, 2010Inventors: Mary Frances Platt, Emyr Lloyd-Evans, Forbes Dennison Porter
-
Patent number: 7772277Abstract: The invention provides novel omega-3 oil formulations comprising fenofibrate and a statin. These formulations are effective in small volumes. Related methods of treatment are also described.Type: GrantFiled: August 3, 2006Date of Patent: August 10, 2010Assignee: TransForm Pharmaceuticals, Inc.Inventors: Orn Almarsson, Hector Guzman, Carolyn Jordan, Julius Remenar
-
Patent number: 7772156Abstract: Microbicidal compositions including (a) cyanodithiocarbimate and (b) an N-alkyl heterocyclic compound; a triazole compound or salt thereof or metal complex thereof; a microbicide with an activated halogen atom or a formaldehyde releasing compound; 1,4-bis(bromoacetoxy)-2-butene; 2-(thiocyanomethylthio)benzothiazole; a methylene-bis(thiocyanate); a halogenated acetophenone; a halopropynl compound; an iodosulfone; a phenol; a halocyanoacetamide compound and/or a quaternary ammonium compound are described. Components (a) and (b) can be present in a synergistically effective amount to control the growth of at least one microorganism. Methods for controlling the growth of microorganisms with the compositions are also disclosed.Type: GrantFiled: November 1, 2006Date of Patent: August 10, 2010Assignee: Buckman Laboratories International, Inc.Inventor: Stephen D. Bryant
-
Publication number: 20100197785Abstract: The present invention relates to an omega-3 fortified composition, method for its production and use of said composition as a nutritional, food or pharmaceutical composition.Type: ApplicationFiled: July 14, 2008Publication date: August 5, 2010Applicant: EPAX ASInventor: Harald Breivik
-
Patent number: 7767714Abstract: Effective preventive method for infectious diseases, an enhancing method of an infectious disease-preventive action of cystine and composition, food and feed effective for infectious diseases are provided. A method of preventing infectious diseases wherein cystine and the like and theanine are administered in combination, a method of enhancing an infectious disease-preventive action of cystine and the like, which contains administering cystine and the like and theanine in combination, a pharmaceutical composition, food and feed wherein cystine and the like and theanine are combined.Type: GrantFiled: August 18, 2004Date of Patent: August 3, 2010Assignee: Ajinomoto Co., Inc.Inventor: Susumu Shibahara
-
Publication number: 20100189755Abstract: The invention relates to substrates impregnated with the skin-treating components which when introduced into a tumbling-type dryer in which it contacts fabric articles, the skin-treating component is transferred to the fabric articles which, when contacted with the skin of a user applies the skin-treating component to human skin.Type: ApplicationFiled: December 7, 2009Publication date: July 29, 2010Applicant: COGNIS IP MANAGEMENT GMBHInventors: Markus Doerr, J. Michael Ogden
-
Publication number: 20100190857Abstract: A lipid-improving agent containing a triglyceride(s) where a poly-unsaturated fatty acid is bonded to 2-position of a triglyceride(s).Type: ApplicationFiled: April 5, 2010Publication date: July 29, 2010Applicant: SUNTORY HOLDINGS LIMITEDInventors: Kengo Akimoto, Harukazu Fukami, Toshinao Goda
-
Patent number: 7763263Abstract: The present invention provides a method for enhancing epidermal permeability barrier function of the aged skin, which includes the step of externally administering to the aged skin an amount of a fumaric acid diester derivative expressed by the following general formula (1) as an active ingredient wherein R1 represents a C1-4 alkylene group; R2 and R3 each represents a linear or branched C1-8 alkyl group; and n is an integer of 2 to 5.Type: GrantFiled: April 7, 2006Date of Patent: July 27, 2010Assignee: Kao CorporationInventors: Hideyo Uchiwa, Sachiyo Hirotsu, Akinori Haratake, Takeshi Ikemoto, Junichi Matsui, Shunsuke Yamazaki, Masaki Yoshida, Motoi Hayase
-
Patent number: 7759507Abstract: The present invention relates to a lipid system, and methods for using such a lipid system, containing specific relative ratios of omega-3, omega-6, and omega-9 fatty acids. The lipid system may be used independently or as a component of a nutritional product. A lipid system according to the present invention may contain omega-3 fatty acids, omega-6 fatty acids, and omega-9 fatty acids with the ratio of omega-6 fatty acids to omega-3 fatty acids preferably being between 0.25:1 and 3:1, and the ratio of omega-9 fatty acids to omega-3 fatty acids preferably being between 0.4:1 and 3:1. The present invention also relates to methods for administering a lipid system or a nutritional product containing the lipid system to an individual.Type: GrantFiled: September 5, 2003Date of Patent: July 20, 2010Assignee: Abbott LaboratoriesInventors: Vikkie A. Mustad, Stephen DeMichele, Bradley A. Zinker, Yung-Sheng Huang
-
Patent number: 7754823Abstract: The present invention is directed to carboxylic acid and ester moieties that are attached to a carbon chain that is between 2 and 24 carbons in length wherein, the chain contains at least one dioxanone ring system, said dioxanone being formed from two adjacent carbons in the chain and/or at least one carbon in the chain is substituted with a pendant dioxanone ring system. In preferred embodiments, the carbon chain is a fatty acid residue. The carbons of said chain can be optionally substituted, saturated or unsaturated. When two or more said ester moieties are present, the invention is directed to a polyester such as a triglyceride, that contains multiple carbon chains wherein each chain is independently derivatized such that the triglyceride contains at least one dioxanone ring system, said dioxanone being formed from two adjacent carbons in at least one of said chains. The present invention is also directed to a method of preparing a dioxanone containing composition or fatty acid derivative.Type: GrantFiled: March 24, 2005Date of Patent: July 13, 2010Assignee: Archer-Daniels-Midland CompanyInventors: Thomas Paul Binder, Paul David Bloom